Susan Bakewell-Sachs, Ph.D., R.N., discusses the possibility and impact of long-term nursing workforce issues, as well as educational capacities across Oregon and the U.S. She says: “Ninety-one percent of OHSU nursing students are from Oregon, and 70 percent stay in the state.”

Richard Maziarz, M.D., discusses key results from the RADIUS clinical trial for acute myeloid leukemia patients.

Brian Druker, M.D., discusses the evolution of kinase inhibitors as anticancer drugs and reviews the current treatment landscape in acute myeloid leukemia.

Amputee demonstrates next-generation prosthetic limb surgically implanted into his bone through a targeted muscle reinnervation surgery performed at OHSU by Albert Chi, M.D.

In response to a new study that shows people with eczema are more likely to have suicidal thoughts and suicide attempts, Eric Simpson, M.D. says the research is consistent with previous studies that demonstrate “a strong association, in children and adults, between having atopic dermatitis (eczema) and mental health conditions such as anxiety and depression.”

Parrot genome study led by Claudio Mello, M.D., Ph.D.

Six 2018 Doernbecher Freestyle patient-designers launch their unique designs for retail availability. Since 2004, Doernbecher Freestyle has raised nearly $24 million.

Doernbecher Freestyle patient-designer Payton Fentress is featured in Runner’s World Magazine.

In response to a study showing that 39 percent of B-cell lymphoma patients treated with Yescarta were still cancer-free two years later, Vinay Prasad, M.D., M.P.H., says “This is in stark contrast with the rhetoric and hype in this space.”

The Winterhawks visit patients at OHSU Doernbecher.